HealthNotableConfirmedDeveloping
8.6
Ryvu Therapeutics and Menarini Group Amend Global Licensing Agreement for Dapolsertib Development
ParkietLO·PL · IT·2 days ago
Researchers identified that the NDRG1 gene facilitates DNA repair in cancer cells, enabling survival against genetic damage. The study suggests that repurposing existing antimalarial drugs to inhibit this mechanism could provide a novel pathway for cancer treatment.